Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamunex for Sickle Cell Acute Pain
NCT01757418Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Nov 2008
- Primary completion
- Dec 2024
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous human immunoglobulin in sickle cell disease (SCD), sponsored by Albert Einstein College of Medicine. Started Nov 2008; status: completed.
02
Drugs
intravenous human immunoglobulin
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01757418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757418.